C

Catalyst Pharmaceuticals
D

CPRX

20.840
USD
0.00
(0.01%)
مغلق
حجم التداول
28,633
الربح لكل سهم
2
العائد الربحي
-
P/E
13
حجم السوق
2,550,628,648
أصول ذات صلة الأخبار المقالات

العنوان: Catalyst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).